{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:15:10Z","timestamp":1791173710125,"version":"4.1.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["NS42091"],"award-info":[{"award-number":["NS42091"]}]},{"name":"NIH","award":["NS59910"],"award-info":[{"award-number":["NS59910"]}]},{"name":"NIH","award":["NS65851"],"award-info":[{"award-number":["NS65851"]}]},{"name":"NIH","award":["DA003194"],"award-info":[{"award-number":["DA003194"]}]},{"name":"NIH","award":["DA012242"],"award-info":[{"award-number":["DA012242"]}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.bcp.2011.06.001","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T11:20:46Z","timestamp":1308914446000},"page":"873-882","source":"Crossref","is-referenced-by-count":86,"title":["Role of \u03b16 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders"],"prefix":"10.1016","volume":"82","author":[{"given":"Maryka","family":"Quik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiomara A.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon R.","family":"Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2011.06.001_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bcp.2011.06.001_bib0010","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1073\/pnas.67.3.1241","article-title":"Use of a snake venom toxin to characterize the cholinergic receptor protein","volume":"67","author":"Changeux","year":"1970","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.06.001_bib0015","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1073\/pnas.84.21.7763","article-title":"Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family","volume":"84","author":"Boulter","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.06.001_bib0020","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/319368a0","article-title":"Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor alpha-subunit","volume":"319","author":"Boulter","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2011.06.001_bib0025","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1523\/JNEUROSCI.05-09-02545.1985","article-title":"Isolation of a clone coding for the alpha-subunit of a mouse acetylcholine receptor","volume":"5","author":"Boulter","year":"1985","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0030","unstructured":"Lamar E, Miller K, Patrick JW. Society for Neuroscience Abstracts; 1990."},{"key":"10.1016\/j.bcp.2011.06.001_bib0035","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/aps.2009.63","article-title":"Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology","volume":"30","author":"Yang","year":"2009","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.bcp.2011.06.001_bib0040","first-page":"1742","article-title":"alpha6-containing nicotinic receptros unmasked in vivo: selective dopaminergic neuronal expression and activation in motor and reward pathways","volume":"5","author":"Tapper","year":"2009","journal-title":"Cell Sci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuron.2008.09.031","article-title":"ACh\/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors?","volume":"60","author":"Calabresi","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2011.06.001_bib0050","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1124\/jpet.105.094375","article-title":"Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy","volume":"316","author":"Quik","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2011.06.001_bib0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2008.07.041","article-title":"Diversity of vertebrate nicotinic acetylcholine receptors","volume":"56","author":"Millar","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2011.06.001_bib0060","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1523\/JNEUROSCI.22-04-01208.2002","article-title":"Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice","volume":"22","author":"Champtiaux","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0065","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/j.1460-9568.1996.tb01206.x","article-title":"Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain","volume":"8","author":"Le Novere","year":"1996","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1096-9861(20000911)425:1<58::AID-CNE6>3.0.CO;2-X","article-title":"Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization","volume":"425","author":"Quik","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0075","unstructured":"Marks M. unpublished."},{"key":"10.1016\/j.bcp.2011.06.001_bib0080","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1046\/j.1460-9568.2000.00262.x","article-title":"Localization of nAChR subunit mRNAs in the brain of Macaca mulatta","volume":"12","author":"Han","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0085","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/cne.902840212","article-title":"Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat","volume":"284","author":"Wada","year":"1989","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0090","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1074\/jbc.271.13.7522","article-title":"A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors","volume":"271","author":"Cartier","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.06.001_bib0095","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1523\/JNEUROSCI.23-21-07820.2003","article-title":"Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice","volume":"23","author":"Champtiaux","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0100","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1523\/JNEUROSCI.22-20-08785.2002","article-title":"Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum","volume":"22","author":"Zoli","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0105","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0026-895X(24)26500-7","article-title":"125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain","volume":"57","author":"Whiteaker","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0110","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1523\/JNEUROSCI.21-15-05494.2001","article-title":"Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey","volume":"21","author":"Quik","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0115","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1124\/mol.105.015925","volume":"68","author":"Gotti","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0120","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1471-4159.2008.05282.x","article-title":"Transport of multiple nicotinic acetylcholine receptors in the rat optic nerve: high densities of receptors containing alpha6 and beta3 subunits","volume":"105","author":"Cox","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2011.06.001_bib0125","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1167\/iovs.08-2398","article-title":"Nicotinic acetylcholine receptor subunits in rhesus monkey retina","volume":"50","author":"Liu","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0130","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1523\/JNEUROSCI.5121-08.2009","article-title":"Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes. But only the {alpha}3{beta}4 and {alpha}3{beta}3{beta}4 subtypes mediate acetylcholine release","volume":"29","author":"Grady","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/mol.104.006015","article-title":"Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or l-DOPA","volume":"67","author":"Quik","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0140","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1523\/JNEUROSCI.5095-09.2010","article-title":"Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement","volume":"30","author":"Gotti","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0145","doi-asserted-by":"crossref","first-page":"11045","DOI":"10.1523\/JNEUROSCI.23-35-11045.2003","article-title":"The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors","volume":"23","author":"Cui","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0150","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1124\/mol.105.011940","article-title":"Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion","volume":"67","author":"Gotti","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0155","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","article-title":"Structural and functional diversity of native brain neuronal nicotinic receptors","volume":"78","author":"Gotti","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1124\/mol.107.035998","article-title":"Nigrostriatal damage preferentially decreases a subpopulation of {alpha}6{beta}2* nAChRs in mouse, monkey and Parkinson's disease striatum","volume":"72","author":"Bordia","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0165","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bcp.2009.06.004","article-title":"Nicotinic acetylcholine receptors and the ascending dopamine pathways","volume":"78","author":"Livingstone","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0170","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1124\/jpet.301.2.651","article-title":"Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions","volume":"301","author":"Grady","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2011.06.001_bib0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1124\/mol.66.1.85","article-title":"Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience","volume":"66","author":"Moretti","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(76)90077-9","article-title":"Nicotinic effect of acetylcholine on the release of newly synthesized (3H)dopamine in rat striatal slices and cat caudate nucleus","volume":"106","author":"Giorguieff","year":"1976","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2011.06.001_bib0185","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1471-4159.1988.tb10582.x","article-title":"Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation","volume":"50","author":"Rapier","year":"1988","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2011.06.001_bib0190","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1471-4159.1992.tb08322.x","article-title":"Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum","volume":"59","author":"Grady","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2011.06.001_bib0195","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.1987.tb01013.x","article-title":"Stimulation of [3H]dopamine release by nicotine in rat nucleus accumbens","volume":"49","author":"Rowell","year":"1987","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2011.06.001_bib0200","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1046\/j.1471-4159.1998.70031069.x","article-title":"Differential inhibition by alpha-conotoxin-MII of the nicotinic stimulation of [3H]dopamine release from rat striatal synaptosomes and slices","volume":"70","author":"Kaiser","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2011.06.001_bib0205","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1523\/JNEUROSCI.17-14-05263.1997","article-title":"Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes","volume":"17","author":"Kulak","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0210","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.106.104414","article-title":"Differential regulation of mesolimbic {alpha}3*\/{alpha}6{beta}2* and {alpha}4{beta}2* nAChR sites and function after long-term oral nicotine to monkeys","volume":"318","author":"McCallum","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2011.06.001_bib0215","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1124\/mol.105.012773","article-title":"Decrease in alpha3*\/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage","volume":"68","author":"McCallum","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0220","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1038\/sj.npp.1301617","article-title":"alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens","volume":"33","author":"Exley","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2011.06.001_bib0225","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1038\/sj.bjp.0707510","article-title":"Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission","volume":"153","author":"Exley","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0230","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1471-4159.2008.05266.x","article-title":"The neuronal nicotinic acetylcholine receptors alpha 4* and alpha 6* differentially modulate dopamine release in mouse striatal slices","volume":"105","author":"Meyer","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2011.06.001_bib0235","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1124\/mol.108.053801","article-title":"Prominent role of {alpha}3\/{alpha}6{beta}2* nAChRs in regulating evoked dopamine release in primate putamen; effect of long-term nicotine treatment","volume":"75","author":"Perez","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0240","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1124\/mol.108.048843","article-title":"Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function","volume":"74","author":"Perez","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0245","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1124\/mol.110.067561","article-title":"{Alpha}6{beta}2* and {alpha}4{beta}2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease","volume":"78","author":"Perez","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0720","first-page":"43","article-title":"Chronic nicotine exposure desensitizes dopaminergic function in the nucleus accumbens","volume":"2","author":"Perex","year":"2011","journal-title":"Nicotinic Acetylcholine Receptor Conference"},{"key":"10.1016\/j.bcp.2011.06.001_bib0260","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nn1244","article-title":"Nicotine amplifies reward-related dopamine signals in striatum","volume":"7","author":"Rice","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0265","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nn1243","article-title":"Frequency-dependent modulation of dopamine release by nicotine","volume":"7","author":"Zhang","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0270","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1523\/JNEUROSCI.0261-09.2009","article-title":"Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine","volume":"29","author":"Zhang","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0275","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1523\/JNEUROSCI.5620-09.2010","article-title":"Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum","volume":"30","author":"Threlfell","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0280","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1124\/mol.110.066159","article-title":"Expression of functional human {alpha}6{beta}2{beta}3* in xenopus oocytes achieved through subunit chimeras and concatamers","volume":"79","author":"Kuryatov","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0285","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pneurobio.2007.12.005","article-title":"It is not \u201ceither\/or\u201d: activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood","volume":"84","author":"Picciotto","year":"2008","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0290","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/jpet.108.145292","article-title":"Desensitization of nicotinic acetylcholine receptors as a strategy for drug development","volume":"328","author":"Buccafusco","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2011.06.001_bib0295","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bcp.2009.06.011","article-title":"Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction","volume":"78","author":"Govind","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0300","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.01.015","article-title":"Neurobiology of nicotine addiction: implications for smoking cessation treatment","volume":"121","author":"Benowitz","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.bcp.2011.06.001_bib0305","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-3565(25)21831-6","article-title":"Effects of chronic nicotine infusion on tolerance development and nicotinic receptors","volume":"226","author":"Marks","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2011.06.001_bib0310","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1471-4159.1988.tb10600.x","article-title":"Evidence that tobacco smoking increases the density of (\u2212)-[3H]nicotine binding sites in human brain","volume":"50","author":"Benwell","year":"1988","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2011.06.001_bib0315","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1523\/JNEUROSCI.12-07-02765.1992","article-title":"Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment","volume":"12","author":"Marks","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0320","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1471-4159.2005.03646.x","article-title":"Increases in alpha4* but not alpha3*\/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment","volume":"96","author":"McCallum","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2011.06.001_bib0325","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-3565(25)20143-4","article-title":"Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels","volume":"278","author":"Pauly","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2011.06.001_bib0330","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0022-3565(24)38304-1","article-title":"Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies","volume":"289","author":"Perry","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2011.06.001_bib0335","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1124\/jpet.110.178236","article-title":"Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain","volume":"337","author":"Marks","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2011.06.001_bib0340","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1471-4159.1985.tb04005.x","article-title":"In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs","volume":"45","author":"Schwartz","year":"1985","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2011.06.001_bib0345","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.bcp.2007.06.040","article-title":"Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation","volume":"74","author":"Nashmi","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0350","doi-asserted-by":"crossref","first-page":"8202","DOI":"10.1523\/JNEUROSCI.2199-07.2007","article-title":"Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path","volume":"27","author":"Nashmi","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0355","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0165-6147(00)01979-9","article-title":"Nicotine addiction: the possible role of functional upregulation","volume":"23","author":"Buisson","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0360","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1124\/mol.104.006429","article-title":"Long-term nicotine treatment decreases striatal alpha6* nicotinic acetylcholine receptor sites and function in mice","volume":"67","author":"Lai","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0365","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.neuroscience.2005.09.008","article-title":"Selective down-regulation of [(125)I]Y(0)-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine","volume":"137","author":"Mugnaini","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2011.06.001_bib0370","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1124\/jpet.107.121228","article-title":"Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain","volume":"322","author":"Perry","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2011.06.001_bib0375","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1124\/mol.105.012419","article-title":"Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors","volume":"68","author":"Kuryatov","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0380","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2005.03.029","article-title":"Nicotine upregulates its own receptors through enhanced intracellular maturation","volume":"46","author":"Sallette","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2011.06.001_bib0385","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1124\/mol.106.027326","article-title":"Beta3 subunits promote expression and nicotine-induced up-regulation of human nicotinic alpha6* nicotinic acetylcholine receptors expressed in transfected cell lines","volume":"70","author":"Tumkosit","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0390","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1074\/jbc.M703432200","article-title":"Upregulation of nicotinic receptors by nicotine varies with receptor subtype","volume":"283","author":"Walsh","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2011.06.001_bib0395","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.tips.2010.12.008","article-title":"Treatment of nicotine addiction: present therapeutic options and pipeline developments","volume":"79","author":"Polosa","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0400","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/B978-0-12-385506-0.00008-9","article-title":"Brain nicotinic receptors as emerging targets for drug addiction neurobiology to translational research","volume":"98","author":"Rahman","year":"2011","journal-title":"Prog Mol Biol Trans Sci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0405","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrn2849","article-title":"Nicotine addiction and nicotinic receptors: lessons from genetically modified mice","volume":"11","author":"Changeux","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0410","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMra0809890","article-title":"Nicotine addiction","volume":"362","author":"Benowitz","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2011.06.001_bib0415","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-8993(94)90401-4","article-title":"Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area","volume":"653","author":"Corrigall","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2011.06.001_bib0420","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02245149","article-title":"The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine","volume":"107","author":"Corrigall","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bcp.2011.06.001_bib0425","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0091-3057(88)90450-9","article-title":"Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection","volume":"30","author":"Goldberg","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2011.06.001_bib0430","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1523\/JNEUROSCI.22-09-03338.2002","article-title":"Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics","volume":"22","author":"Picciotto","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0435","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/FBP.0b013e32830c360e","article-title":"Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice","volume":"19","author":"Fowler","year":"2008","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0440","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-3-540-69248-5_8","article-title":"The neuronal pathways mediating the behavioral and addictive properties of nicotine","author":"Balfour","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0445","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/34413","article-title":"Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine","volume":"391","author":"Picciotto","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2011.06.001_bib0450","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature03694","article-title":"Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors","volume":"436","author":"Maskos","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2011.06.001_bib0455","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1099420","article-title":"Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization","volume":"306","author":"Tapper","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bcp.2011.06.001_bib0460","doi-asserted-by":"crossref","first-page":"12318","DOI":"10.1523\/JNEUROSCI.3918-08.2008","article-title":"Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration","volume":"28","author":"Pons","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0465","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/npp.2009.171","article-title":"alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine","volume":"35","author":"Brunzell","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2011.06.001_bib0470","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/jpet.109.155457","article-title":"The role of {alpha}6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal","volume":"331","author":"Jackson","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2011.06.001_bib0475","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1523\/JNEUROSCI.2056-10.2010","article-title":"Cholinergic modulation of locomotion and striatal dopamine release is mediated by {alpha}6{alpha}4* nicotinic acetylcholine receptors","volume":"30","author":"Drenan","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0480","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/npp.2010.240","article-title":"Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area","volume":"36","author":"Zhao-Shea","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2011.06.001_bib0485","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1073\/pnas.0702698104","article-title":"Long-term effects of chronic nicotine exposure on brain nicotinic receptors","volume":"104","author":"Besson","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2011.06.001_bib0490","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1055\/s-0029-1220690","article-title":"Mechanistic studies of ethanol's interaction with the mesolimbic dopamine reward system","volume":"42","author":"Soderpalm","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.bcp.2011.06.001_bib0495","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/mol.106.025130","article-title":"Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors","volume":"70","author":"Mihalak","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0500","unstructured":"Quik M. unpublished observation."},{"key":"10.1016\/j.bcp.2011.06.001_bib0505","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.neuropharm.2010.01.013","article-title":"Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptors","volume":"58","author":"Grady","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2011.06.001_bib0510","doi-asserted-by":"crossref","first-page":"12518","DOI":"10.1073\/pnas.0705368104","article-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking","volume":"104","author":"Steensland","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.06.001_bib0515","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00213-007-0899-4","article-title":"Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues","volume":"195","author":"Lof","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bcp.2011.06.001_bib0520","first-page":"5","article-title":"Nicotinic acetylcholine receptors containing the alpha4 subunit are critical for the nicotine-induced reduction of acute voluntary ethanol consumption","author":"Hendrickson","year":"2011","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.bcp.2011.06.001_bib0525","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopsych.2009.01.029","article-title":"Varenicline reduces alcohol self-administration in heavy-drinking smokers","volume":"66","author":"McKee","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bcp.2011.06.001_bib0530","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1523\/JNEUROSCI.2601-10.2010","article-title":"Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption","volume":"30","author":"Hendrickson","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0535","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/npp.2010.191","article-title":"Partial agonists of the alpha3beta4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats","volume":"36","author":"Chatterjee","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2011.06.001_bib0540","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.alcohol.2004.10.002","article-title":"Is an alpha-conotoxin MII-sensitive mechanism involved in the neurochemical, stimulatory, and rewarding effects of ethanol?","volume":"34","author":"Larsson","year":"2004","journal-title":"Alcohol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0545","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1097\/00001756-199908200-00012","article-title":"Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion","volume":"10","author":"le Novere","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.bcp.2011.06.001_bib0550","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuron.2008.09.009","article-title":"In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors","volume":"60","author":"Drenan","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2011.06.001_bib0555","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1046\/j.1460-9568.2003.02564.x","article-title":"Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors","volume":"17","author":"Marubio","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0560","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.euroneuro.2008.02.006","article-title":"Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens","volume":"18","author":"Jerlhag","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0565","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0306-4522(00)00244-X","article-title":"Differential alterations in nicotinic receptor alpha6 and beta3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration","volume":"100","author":"Quik","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2011.06.001_bib0570","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1124\/mol.63.5.1169","article-title":"Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice","volume":"63","author":"Quik","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0575","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/mol.61.1.230","article-title":"Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites","volume":"61","author":"Kulak","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0580","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.expneurol.2004.10.004","article-title":"Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus","volume":"191","author":"Bohr","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0585","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nbd.2006.04.005","article-title":"Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease. Parkinson's disease and dementia with Lewy bodies by immunoprecipitation","volume":"23","author":"Gotti","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bcp.2011.06.001_bib0590","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1471-4159.2004.02177.x","article-title":"Loss of alpha-conotoxinMII- and A85380-sensitive nicotinic receptors in Parkinson's disease striatum","volume":"88","author":"Quik","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2011.06.001_bib0595","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tips.2007.03.001","article-title":"Nicotine neuroprotection against nigrostriatal damage: importance of the animal model","volume":"28","author":"Quik","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0600","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2174\/1568007023339166","article-title":"The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration","volume":"1","author":"O\u2019Neill","year":"2002","journal-title":"Curr Drug Target CNS Neurol Disord"},{"key":"10.1016\/j.bcp.2011.06.001_bib0605","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2741\/2695","article-title":"Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease","volume":"13","author":"Picciotto","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0610","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1471-4159.2009.06011.x","article-title":"Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys","volume":"109","author":"Huang","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2011.06.001_bib0615","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1468-1331.2009.02697.x","article-title":"Levodopa in the treatment of Parkinson's disease","volume":"16","author":"Schapira","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0620","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1212\/WNL.0b013e31819908ce","article-title":"Treatments for Parkinson disease\u2014past achievements and current clinical needs","volume":"72","author":"Poewe","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2011.06.001_bib0625","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1212\/WNL.0b013e318198e177","article-title":"When and how should treatment be started in Parkinson disease?","volume":"72","author":"Lang","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2011.06.001_bib0630","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1002\/ana.21453","article-title":"How do you treat motor complications in Parkinson's disease: medicine, surgery, or both?","volume":"64","author":"Fahn","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0635","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1517\/14656561003598919","article-title":"Levodopa in Parkinson's disease: from the past to the future","volume":"11","author":"Pezzoli","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bcp.2011.06.001_bib0640","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.bcp.2011.06.001_bib0645","unstructured":"Huang LZ, Bordia T, Quik M. Nicotine treatment reduces l-dopa-induced dyskinetic-like movements in parkinsonian mice. Society for Neuroscience Abstracts; 2009."},{"key":"10.1016\/j.bcp.2011.06.001_bib0650","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1124\/jpet.108.140897","article-title":"Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (l-DOPA)-induced dyskinesias in a rat model of Parkinson's disease","volume":"327","author":"Bordia","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2011.06.001_bib0655","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ana.21203","article-title":"Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys","volume":"62","author":"Quik","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0660","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1124\/jpet.109.162396","article-title":"Nicotinic receptor-mediated reduction in l-dopa-induced dyskinesias may occur via desensitization","volume":"333","author":"Bordia","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2011.06.001_bib0665","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.tips.2007.05.003","article-title":"Rationale, pharmacology and clinical efficacy of partial agonists of alpha(4)beta(2) nACh receptors for smoking cessation","volume":"28","author":"Rollema","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2011.06.001_bib0670","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1471-4159.2002.00868.x","article-title":"5-Iodo-A-85380 binds to alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors (nAChRs) as well as alpha4beta2* subtypes","volume":"81","author":"Kulak","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2011.06.001_bib0675","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.neuropharm.2010.12.032","article-title":"Nicotinic receptor agonists decrease l-dopa-induced dyskinesias most effectively in moderately lesioned parkinsonian rats","volume":"60","author":"Huang","year":"2011","journal-title":"Neuropharmacology"},{"issue":"Suppl. 2","key":"10.1016\/j.bcp.2011.06.001_bib0680","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.parkreldis.2008.04.023","article-title":"Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence","volume":"14","author":"Carta","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl. 2","key":"10.1016\/j.bcp.2011.06.001_bib0685","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1016\/j.parkreldis.2008.04.021","article-title":"Involvement of the serotonin system in l-dopa-induced dyskinesias","volume":"14","author":"Carta","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.bcp.2011.06.001_bib0690","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0079-6123(10)83011-0","article-title":"Maladaptive striatal plasticity in l-DOPA-induced dyskinesia","volume":"183C","author":"Cenci","year":"2010","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.bcp.2011.06.001_bib0695","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.nurt.2008.01.006","article-title":"Deep brain stimulation for Parkinson's disease","volume":"5","author":"Limousin","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bcp.2011.06.001_bib0700","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.281.5379.985","article-title":"Cholinergic switching within neocortical inhibitory networks","volume":"281","author":"Xiang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bcp.2011.06.001_bib0705","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1126\/science.1195320","article-title":"Lynx1, a cholinergic brake, limits plasticity in adult visual cortex","volume":"330","author":"Morishita","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bcp.2011.06.001_bib0710","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1124\/mol.65.6.1526","article-title":"Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice","volume":"65","author":"Salminen","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.001_bib0715","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/mol.65.6.1333","article-title":"Getting past the asterisk: the subunit composition of presynaptic nicotinic receptors that modulate striatal dopamine release","volume":"65","author":"Luetje","year":"2004","journal-title":"Mol Pharmacol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211003662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211003662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T15:52:22Z","timestamp":1741276342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295211003662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":142,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0006295211003662"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2011.06.001","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}